Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice

Journal of Clinical Investigation

Volumn 121, Issue 1, 2011, Pages 249-264

  Liu, Yawei ^a,b   Teige, Anna ^b   Mondoc, Emma ^b,c   Ibrahim, Saleh ^d   Holmdahl, Rikard ^b,c   Issazadeh Navikas, Shohreh ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; HYPERSENSITIVITY; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, CD95; ARTHRITIS, EXPERIMENTAL; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; COLLAGEN TYPE II; DNA PRIMERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FAS LIGAND PROTEIN; GENES, MHC CLASS II; GENES, T-CELL RECEPTOR; HYPERSENSITIVITY, DELAYED; IMMUNODOMINANT EPITOPES; INFLAMMATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; PEPTIDE FRAGMENTS; RESPIRATORY HYPERSENSITIVITY; TH1 CELLS; TH2 CELLS; VACCINATION;

EID: 78650963869     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI43964     Document Type: Article

References (48)

1. Issazadeh S, Kjellen P, Olsson T, Mustafa M, Holmdahl R. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific. Eur J Immunol. 1997;27(6):1584-1587. (Pubitemid 27254855)
2. Brunsberg U, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol. 1994;24(7):1698-1702.
3. Holmdahl R, Jansson L, Larsson E, Rubin K, Klareskog L. Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum. 1986;29(1):106-113.
4. Bayrak S, et al. T cell response of I-Aq mice to self type II collagen: meshing of the binding motif of the I-Aq molecule with repetitive sequences results in autoreactivity to multiple epitopes. Int Immunol. 1997;9(11):1687-1699.
5. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25:297-336.
6. Gapin L. iNKT cell autoreactivity: what is 'self ' and how is it recognized? Nat Rev Immunol. 2010;10(4):272-277.
7. Castano AR, et al. Peptide binding and presentation by mouse CD1. Science. 1995;269(5221):223-226.
8. Tangri S, Brossay L, Burdin N, Lee DJ, Corr M, Kronenberg M. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. Proc Natl Acad Sci U S A. 1998;95(24):14314-14319. (Pubitemid 28549364)
9. Zeng Z, Castaño AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science. 1997;277(5324):339-345.
10. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest. 2004;114(10):1379-1388.
11. van der Vliet HJ, et al. The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin Immunol. 2004;112(1):8-23.
12. Cardell S. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin Exp Immunol. 2005;143(2):194-202.
13. Van Kaer L. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol. 2005;5(1):31-42.
14. Mallevaey T, et al. T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity. 2009;31(1):60-71.
15. Nagata S. Fas-induced apoptosis, and diseases caused by its abnormality. Genes Cells. 1996;1(10):873-879. (Pubitemid 126670795)
16. Lee KA, et al. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. Cell Immunol. 2008;251(1):50-55.
17. Lee DJ, Abeyratne A, Carson DA, Corr M. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo. J Exp Med. 1998;187(3):433-438.
18. Chan AC, et al. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 1995;14(11):2499-2508.
19. Uldrich AP, et al. NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge. J Immunol. 2005;175(5):3092-3101.
20. Brossay L, Tangri S, Bix M, Cardell S, Locksley R, Kronenberg M. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. J Immunol. 1998;160(8):3681-3688.
21. Coquet JM, et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A. 2008;105(32):11287-11292.
22. Koenders MI, van den Berg WB. Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity? Clin Exp Immunol. 2010;159(2):131-136.
23. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev. 2008;226:87-102.
24. Haak S, et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest. 2009;119(1):61-69.
25. Liu Y, Teige I, Ericsson I, Navikas V, Issazadeh-Navikas S. Suppression of EAE by oral tolerance is independent of endogenous IFN-beta whereas treatment with recombinant IFN-beta ameliorates EAE. Immunol Cell Biol. 2010;88(4):468-476.
26. Teige A, Bockermann R, Hasan M, Olofsson KE, Liu Y, Issazadeh-Navikas S. CD1d-dependent NKT cells play a protective role in acute and chronic arthritis models by ameliorating antigen-specific Th1 responses. J Immunol. 2010;185(1):345-356.
27. Ito H, Seishima M. Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell. J Biomed Biotechnol. 2010;2010:641757.
28. Teige A, et al. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J Immunol. 2004;172(1):186-194.
29. Kawano T, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A. 1998;95(10):5690-5693.
30. Arase N, Arase H, Good RA, Onoe K. Contribution of host radioresistant T cells to the clonal elimination of minor lymphocyte stimulatory-1a reactive T cells in mouse bone marrow chimeras. Cell Immunol. 1994;156(1):13-23.
31. Moroda T, et al. Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules. Immunology. 1997;91(2):219-226.
32. Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia. 2003;17(6):1068-1077.
33. Wu L, Gabriel CL, Parekh VV, Van Kaer L. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Tissue Antigens. 2009;73(6):535-545.
34. Haeryfar SM. Invariant natural killer T cells in immune surveillance and tumor immunotherapy: perspectives and potentials. Arch Iran Med. 2008;11(2):186-195.
35. Van Kaer L. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunol Cell Biol. 2004;82(3):315-322.
36. Taams LS, Akbar AN. Peripheral generation and function of CD4+CD25+ regulatory T cells. Curr Top Microbiol Immunol. 2005;293:115-131.
37. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med. 2006;12(5):518-525.
38. Van Kaer L. Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol Res. 2004;30(2):139-153. (Pubitemid 39425338)
39. Novak J, Beaudoin L, Griseri T, Lehuen A. Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J Immunol. 2005;174(4):1954-1961.
40. Hegde S, Chen X, Keaton JM, Reddington F, Besra GS, Gumperz JE. NKT cells direct monocytes into a DC differentiation pathway. J Leukoc Biol. 2007;81(5):1224-1235.
41. Chen YG, et al. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol. 2005;174(3):1196-1204.
42. Campos RA, et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med. 2003;198(12):1785-1796.
43. Mak TW, Rahemtulla A, Schilham M, Koh DR, Fung-Leung WP. Generation of mutant mice lacking surface expression of CD4 or CD8 by gene targeting. J Autoimmun. 1992;5 suppl A:55-59.
44. Smiley ST, Kaplan MH, Grusby MJ. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science. 1997;275(5302):977-979. (Pubitemid 27087713)
45. Teige A, Bockermann R, Hasan M, Olofsson KE, Liu Y, Issazadeh-Navikas S. CD1d-dependent NKT cells play a protective role in acute and chronic arthritis models by ameliorating antigen-specific Th1 responses. J Immunol. 2010;185(1):345-356.
46. Holmdahl R. Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol. 1998;10(6):710-717.
47. Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 2004;50(1):305-313.
48. Teige I, et al. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol. 2003;170(9):4776-4784.